# China NMPA Inspection - Wuhan Runhe Biomedical Co., Ltd. - January 02, 2020

Source: https://www.globalkeysolutions.net/records/china_inspection/wuhan-runhe-biomedical-co-ltd/07292076-efcf-4c4f-8fdf-69ee7fb2b3e3/
Source feed: China

> China NMPA unannounced inspection for Wuhan Runhe Biomedical Co., Ltd. published January 02, 2020. The National Medical Products Administration (NMPA) in China, operating under its regulatory framework for drug administration, issued a formal notifi

---

## Details

- Record Type: CHINA_INSPECTION
- Title: Notification of Unannounced Inspection of Wuhan Runhe Biomedical Co., Ltd.
- Company Name: Wuhan Runhe Biomedical Co., Ltd.
- Publication Date: 2020-01-02
- Product Type: Biologics
- Summary: The National Medical Products Administration (NMPA) in China, operating under its regulatory framework for drug administration, issued a formal notification concerning an unannounced inspection targeting Wuhan Runhe Biopharmaceutical Co., Ltd. This significant regulatory action, documented with index number JGXX-2020-10001, was publicly announced on January 2, 2020. The notification signifies the NMPA's proactive approach to ensuring compliance within the pharmaceutical sector through surprise audits.

The document explicitly names Wuhan Runhe Biopharmaceutical Co., Ltd. as the subject of this unannounced scrutiny. However, the provided content is limited to the notification itself. Consequently, specific details regarding the actual dates when the inspection took place, any identified main violations or non-compliance issues discovered during the audit, or any subsequent required corrective actions to be undertaken by the company are not included within this public announcement. This notification primarily serves as a record of the initiation of a regulatory oversight process, confirming that the company was slated for, or had undergone, a surprise evaluation by the NMPA to uphold drug quality and safety standards. Further information regarding the inspection's findings or outcomes would typically be found in a subsequent, more detailed report, which is not part of the provided text.

Company: https://www.globalkeysolutions.net/companies/wuhan-runhe-biomedical-co-ltd/10e5ebdc-66d5-4962-9a2e-314d29141349/